Phaseline

Targets › VZVA

VZVA: drug programs, companies and trials

1 program from 1 company in 4 trials: 2 Phase 2, 2 Phase 1; Infectious disease.

Open in Phaseline: the race on VZVA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
MAXVAX Biotechnology Limited Liability CompanyRecombinant Herpes Zoster Vaccine (CHO cells) with low dose MA105
Recombinant varicella zoster virus glycoprotein E vaccine with low dose MA105 adjuvant
VZV, VZVAPhase 2Herpes Zoster–

Conditions

Herpes Zoster (4)

Modalities

mixed (1)

Companies

MAXVAX Biotechnology Limited Liability Company (1)

Related targets

VZV (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.